Identification and assessment of PLK1/2/3/4 in lung adenocarcinoma and lung squamous cell carcinoma: Evidence from methylation profile

Lung cancer is a very aggressive cancer characterized with molecular heterogeneities in different subtypes, including lung adenocarcinoma and lung squamous cell carcinoma. However, few related molecular signatures have been established for the treatment of lung cancer subtypes. Polo‐like kinase (PLK...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Sisi, Lu, Xiaoli, Zhang, Zhi, Meng, Rui, Li, Mi, Xia, Shilin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8278123/
https://www.ncbi.nlm.nih.gov/pubmed/34080290
http://dx.doi.org/10.1111/jcmm.16668

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8278123/
https://www.ncbi.nlm.nih.gov/pubmed/34080290
http://dx.doi.org/10.1111/jcmm.16668

Ejemplares similares